These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 15812472)
21. Who will benefit from treatment with selective estrogen receptor modulators (SERMs)? Sambrook P Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):975-81. PubMed ID: 16301191 [TBL] [Abstract][Full Text] [Related]
27. Selective estrogen receptor modulators: A possible new treatment of osteoporosis in males. Kastelan D; Giljevic Z; Kraljevic I; Korsic M Med Hypotheses; 2006; 67(5):1052-3. PubMed ID: 16790322 [TBL] [Abstract][Full Text] [Related]
28. Five female cases of prolonged depression in chronic anorexia nervosa treated with selective estrogen receptor modulator raloxifene-augmented therapy. Yokoyama S; Sugiyama N; Sugiyama E; Amano N J Clin Psychopharmacol; 2008 Dec; 28(6):721-2. PubMed ID: 19011455 [No Abstract] [Full Text] [Related]
29. Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma. Sonpavde G; Okuno N; Weiss H; Yu J; Shen SS; Younes M; Jian W; Lerner SP; Smith CL Urology; 2007 Jun; 69(6):1221-6. PubMed ID: 17572228 [TBL] [Abstract][Full Text] [Related]
30. Application of selective estrogen receptor modulators for breast cancer treatment according to their intrinsic nature. Saji S; Kuroi K Breast Cancer; 2008; 15(4):262-9. PubMed ID: 18654829 [TBL] [Abstract][Full Text] [Related]
31. Letter by Choi et al regarding article, "Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the raloxifene use for the heart trial: results of subgroup analyses by age and other factors". Choi BG; Vilahur G; Badimon JJ Circulation; 2009 Oct; 120(17):e147; author reply e148. PubMed ID: 19858421 [No Abstract] [Full Text] [Related]
32. Selective agonists of estrogen receptor isoforms: new perspectives for cardiovascular disease. Bolego C; Vegeto E; Pinna C; Maggi A; Cignarella A Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2192-9. PubMed ID: 16917104 [TBL] [Abstract][Full Text] [Related]
34. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance. Lewis JS; Jordan VC Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919 [TBL] [Abstract][Full Text] [Related]
35. [Letter: Gynecomastia in puberty]. Bettex M; Teller W Anasthesiol Intensivmed Prax; 1974; 9(1):114. PubMed ID: 4464785 [No Abstract] [Full Text] [Related]
36. Comment to Dr. Yatham regarding tamoxifen listed as a third-line recommendation for the pharmacological treatment of acute mania. Shen CC; Bai YM; Su TP Bipolar Disord; 2009 Nov; 11(7):773-5; author reply 775. PubMed ID: 19840002 [No Abstract] [Full Text] [Related]
37. Raloxifene for hormone replacement therapy (HRT). Adams D N Z Med J; 2005 May; 118(1214):U1451. PubMed ID: 15886741 [No Abstract] [Full Text] [Related]
38. Alternatives for menopause. Ernst E; Borrelli F Arch Intern Med; 2007 Mar; 167(5):515; author reply 515-6. PubMed ID: 17353503 [No Abstract] [Full Text] [Related]
39. Selective reduction of estrogen receptor (ER) positive breast cancer occurrence by estrogen receptor modulators supports etiological distinction between ER positive and ER negative breast cancers. Kurbel S Med Hypotheses; 2005; 64(6):1182-7. PubMed ID: 15823713 [TBL] [Abstract][Full Text] [Related]
40. Prevention of breast cancer using selective oestrogen receptor modulators (SERMs). Powles TJ Breast Cancer Res; 2006; 8(5):111. PubMed ID: 17049068 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]